Integrin-linked kinase: A cancer therapeutic target unique among its ILK

Nature Reviews Cancer

Volumn 5, Issue 1, 2005, Pages 51-63

  Hannigan, Gregory ^a   Troussard, Armelle A ^b   Dedhar, Shoukat ^b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADAPTOR PROTEIN; CANCER GROWTH FACTOR; CELL RECEPTOR; GROWTH FACTOR; INTEGRIN; INTEGRIN LINKED KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE B; UVOMORULIN; VASCULOTROPIN;

ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CANCER THERAPY; CELL ADHESION; CELL DIVISION; CELL INTERACTION; COMPLEX FORMATION; CYTOSKELETON; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; NEOPLASMS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 11144225205     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1524     Document Type: Review

References (133)

1. Hannigan, G. E. et al. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature 379, 91-96 (1996). First report of the identification of ILK. Demonstration of an interaction with β1-integrin cytoplasmic domain and function in the regulation of anchorage-dependent growth of epithelial cells.
2. Zervas, C. G., Gregory, S. L. & Brown, N. H. Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane. J. Cell Biol. 152, 1007-1018 (2001).
3. Mackinnon, A. C., Qadota, H., Norman, K. R., Moerman, D. G. & Williams, B. D. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr. Biol. 12, 787-797 (2002). References 2 and 3 provide genetic evidence in model oganisms for the integrin-ILK connection and show conserved evolutionary function of ILK.
4. Sakai, T. et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev. 17, 926-940 (2003).
5. Brakebusch, C. & Fassler, R. The integrin-actin connection, an eternal love affair. EMBO J. 22, 2324-2333 (2003).
6. Wu, C. The PINCH-ILK-parvin complexes: assembly, functions and regulation. Biochim. Biophys. Acta 1692, 55-62 (2004).
7. Wu, C. & Dedhar, S. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol. 155, 505-510 (2001).
8. Yamaji, S. et al. Affixin interacts with α-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell-substrate interaction. J. Cell Biol. 165, 539-551 (2004).
9. Yamaji, S. et al. Possible role of ILK-affixin complex in integrin-cytoskeleton linkage during platelet aggregation. Biochem. Biophys. Res. Commun. 297, 1324-1331 (2002).
10. Persad, S. & Dedhar, S. The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev. 22, 375-384 (2003).
11. Oloumi, A., McPhee, T. & Dedhar, S. Regulation of E-cadherin expression and β-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim. Bophys. Acta 1691, 1-15 (2004).
12. 2+-independent smooth muscle contraction, a novel function for integrin-linked kinase. J. Biol. Chem. 276, 16365-16373 (2001). An unbiased approach providing biochemical data demonstrating that ILK is a bona fide serine/threonine protein kinase.
13. Vouret-Craviari, V., Boulter, E., Grall, D., Matthews, C. & Van Obberghen-Schilling, E. ILK is required for the assembly of matrix-forming adhesions and capillary morphogenesis in endothelial cells. J. Cell Sci. 117, 4539-4569 (2004).
14. Friedrich, E. B. et al. Integrin-linked kinase regulates endothelial cell survival and vascular develpment. Mol. Cell. Biol. 24, 8134-8144 (2004). Endothelial-cell-specific knockout demonstrating an essential role of ILK in vascular development and angiogenesis. Demonstrates an essential role of ILK in the control of endothelial-cell survival.
15. Tan, C. et al. Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5, 79-90 (2004). Shows that ILK can promote the expression and synthesis of VEGF by prostate cancer cells, and also that ILK is required for VEGF-induced angiogenic response. Also shows the efficacy of ILK inhibitors in suppressing tumour angiogenesis and growth in vivo, and provides a framework for ILK as a two-hit therapeutic target for tumour angiogenesis.
16. Kaneko, Y., Kitazato, K., & Basaki, Y. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. J. Cell Sci. 117, 407-415 (2004).
17. Persad, S. et al. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino adds arginine 211 and serine 343. J. Biol. Chem. 276, 27462-27469 (2001). In depth biochemical analysis of ILK as a Ser473 kinase for AKT. Characterization of critical amino acids involved in the regulation of ILK activity, and characterization of small-molecule ILK inhibitors.
18. -/- human colon carcinoma cells. Oncogene 20, 133-140 (2001).
19. DeMali, K. A., Wennerberg, K. & Burridge, K. Integrin signaling to the actin cytoskeleton. Curr. Opin. Cell Biol. 15, 572-582 (2003).
20. Sanger, J. W. & Holtzer, H. Cytochalasin B: effects on cell morphology, cell adhesion, and mucopolysaccharide synthesis (cultured cells-contractile microfilaments-glycoproteins-embryonic cells-sorting-out). Proc. Natl Acad. Sci. USA 69, 253-257 (1972).
21. Otey, C. A., Vasquez, G. B., Burridge, K. & Erickson, B. W. Mapping of the α-actinin binding site within the β1 integrin cytoplasmic domain. J. Biol. Chem. 268, 21193-21197 (1993).
22. Wang, N., Butler, J. P. & Ingber, D. E. Mechanotransduction across the cell surface and through the cytoskeleton. Science 260, 1124-1127 (1993).
23. Stiles, C. D. et al. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl Acad Sci. USA 76, 1279-1283 (1979).
24. McNamee, H. P., Ingber, D. E. & Schwartz, M. A. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J. Cell Biol. 121, 673-678 (1993).
25. Kornberg, L. J., Earp, H. S., Turner, C. E., Prockop, C. & Juliano, R. L. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins. Proc. Natl Acad Sci. USA 88, 8392-8396 (1991).
26. Kornberg, L., Earp, H. S., Parsons, J. T., Schaller, M. & Juliano, R. L. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267, 23439-23442 (1992).
27. Lukashev, M. E., Sheppard, D. & Pytela, R. Disruption of integrin function and induction of tyrosine phosphorylation by the autonomously expressed β1 integrin cytoplasmic domain. J. Biol. Chem. 269, 18311-18314 (1994).
28. Hannigan, G. E. et al. Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15. 5-p15.4. Genomes 42, 177-179 (1997).
29. Tu, Y., Li, F., Goicoechea, S. & Wu, C. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol. Cell. Biol. 19, 2425-2434 (1999). First identification of the interaction of ILK with PINCH, an evolutionary conserved protein required for various ILK functions.
30. Leung-Hagestejn, C., Mahendra, A., Naruszewicz, I. & Hannigan, G. E. Modulation of integrin signa transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. EMBO J. 20, 2160-2170 (2001). Important finding identifying a negative regulator of ILK activity.
31. Yamaji, S. et al. A novel integrin-linked kinase-binding protein, affixin, is involved in the early stage of cell-substrate interaction. J. Cell Biol. 153, 1251-1264 (2001).
32. Tu, Y., Huang, Y., Zhang, Y., Hua, Y. & Wu, C. A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading, J. Cell Biol. 153, 585-598 (2001). References 31 and 32 describe the identification and interactions with ILK of β-parvin and α-parvin, respectively, and the roles of their interactions with ILK on cell spreading.
33. Hanks, S. K. & Hunter, T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596 (1995).
34. Hanks, S. K. & Quinn, A. M. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200, 38-62 (1991).
35. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912-1934 (2002).
36. Jenne, D. E. et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genet. 18, 38-43 (1998).
37. Mehenni, H. et al. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 63, 1641-1650 (1998).
38. Boudeau, J. et al. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients. Hum. Mutat. 21, 172 (2003).
39. Zervas, C. G. & Brown, N. H. Integrin adhesion: when is a kinase a kinase? Curr. Biol. 12, R350-R351 (2002).
40. Attwel, S., Roskelley, C. & Dedhar, S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19, 3811-3815 (2000).
41. Radeva, G. et al. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem. 272, 13937-13944 (1997). This study showed that ILK can coordinate adhesion-dependent cell-cycle regulation.
42. Miller, M. G., Naruszewicz, I., Kumar, A. S., Ramlal, T. & Hannigan, G. E. Integrin-linked kinase is a positive mediator of L6 myoblast differentiation. Biochem. Biophys. Res. Commun. 310, 796-803 (2003).
43. Attwel, S., Mills, J., Troussard, A., Wu, C. & Dedhar, S. Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN. Mol. Biol. Cell 14, 4813-4825 (2003). This work shows the integrated function of ILK as a kinase and an adaptor in focal adhesions.
44. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793 (1997).
45. Delcommenne, M. et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl Acad. Sci. USA 95, 11211-11216 (1998).
46. Lynch, D. K., Ellis, C. A., Edwards, P. A. & Hiles, I. D. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18, 8024-8032 (1999). References 45 and 46 showed that ILK activity is regulated in a PI3K-dependent manner, and that ILK regulates AKT Ser473 phosphorylation in a PI3K-dependent manner.
47. Persad, S. et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc. Natl Acad. Sci. USA 97, 3207-3212 (2000). References 47 and 56 show that PTEN negatively regulates ILK activity and that loss of PTEN results in constitutively activated ILK. Inhibition of ILK in PTEN-negative cells inhibits tumour-cell growth and inhibits AKT activation.
48. Cruet-Hennequart, S. et al. α integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22, 1688-1702 (2003).
49. Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998).
50. Leslie, N. R. & Downes, C. P. PTEN: The down side of PI 3-kinase signaling. Cell Signal. 14, 285-295 (2002).
51. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997).
52. Cairns, P. et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57, 4997-5000 (1997).
53. Whang, Y. E. et al. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl Acad. Sci. USA 95, 5246-5250 (1998).
54. Myers, M. P. et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl Acad. Sci. USA 95, 13513-13518 (1998).
55. Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998).
56. Morimoto, A. M. et al. The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity. Oncogene 19, 200-209 (2000).
57. Persad, S., Troussard, A. A., McPhee, T. R., Mulholland, D. J. & Dedhar, S. Tumor suppressor PTEN inhibits nuclear accumulation of β-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol. 153, 1161-1174 (2001).
58. Obara, S. et al. Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. Cancer Lett. 208, 115-122 (2004).
59. Mok, S. C. et al. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 16, 2381-2387 (1998).
60. Kleeff, J. et al. Down-regulation of DOC-2 in colorectal cancer points to is role as a tumor suppressor in this malignancy. Dis. Colon Rectum 45, 1242-1248 (2002).
61. Hoek, K. et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 64, 5270-5282 (2004).
62. Dai, D. L. et al. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin. Cancer Res. 9, 4409-4414 (2003).
63. Takada, T. et al. Induction of apoptosis by stomach cancer-associated protein-tyrosine phosphatase-1. J. Biol. Chem. 277, 34359-34366 (2002).
64. Fumoto, K., Uchimura, T., Iwasaki, T., Ueda, K. & Hosoya, H. Phosphorylation of myosin II regulatory light chain is necessary for migration of HeLa cells but not for localization of myosin II at the leading edge. Biochem. J. 370, 551-556 (2003).
65. Uchimura, T., Fumoto, K., Yamamoto, Y., Ueda, K. & Hosoya, H. Spatial localization of mono-and diphosphorylated myosin II regulatory light chain at the leading edge of motile HeLa cells. Cell Struct. Funct. 27, 479-486 (2002).
66. Matsumura, F., Ono, S., Yamakita, Y., Totsukawa, G. & Yamashino, S. Specific localization of serine 19 phosphorated myosin II during cell locomotion and mitosis of cultured cells. J. Cell Biol. 140, 119-129 (1998).
67. Deng, J. T., Sutherland, C., Brautigan, D. L., Eto, M. & Walsh, M. P. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem. J. 367, 517-524 (2002).
68. Erdodi, F. et al. Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 306, 382-387 (2003).
69. Zhang, Y., Guo, L., Chen, K. & Wu, C. A critical role of the PINCH-integrin-tinked kinase interaction in the regulation of cell shape change and migration. J. Biol. Chem. 277, 318-326 (2002).
70. Velyvis, A., Yang, Y., Wu, C. & Qin, J. Solution structure of the focal adhesion adaptor PINCH LIM1 domain and characterization of its interaction with the integrin-linked kinase ankyrin repeat domain. J. Biol. Chem. 276, 4932-4939 (2001).
71. Li, F., Zhang, Y. & Wu, C. Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats. J. Cell Sci. 112, 4589-4599 (1999).
72. Fukuda, T., Chen, K., Shi, X. & Wu, C. PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J. Biol. Chem. 278, 51324-51333 (2003).
73. Zhang, Y., Chen, K., Guo, L. & Wu, C. Characterization of PINCH-2, a new focal adhesion protein that regulates the PINCH-1-ILK interaction, cell spreading, and migration. J. Biol. Chem. 277, 38328-38338 (2002).
74. Braun, A. et al. PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. Exp. Cell Res. 284, 239-250 (2003).
75. Olski, T. M., Noegel, A. A. & Korenbaum, E. Parvin, a 42 kDa focal adhesion protein, related to the α-actinin superfamily. J. Cell Sci. 114, 525-538 (2001).
76. Nikolopoulos, S. N. & Turner, C. E. Molecular dissection of actopaxin-integrin-linked kinase-paxillin interactions and their role in subcellular localization. J. Biol. Chem. 277, 1568-1575 (2002).
77. Mongroo, P. et al. β-parvin inhibits integrin linked kinase signaling and is down-regulated in breast cancer. Oncogene 23, 8959-8970 (2004).
78. Fukuda, T., Guo, L., Shi, X. & Wu, C. CH-ILKBP regulates cell survival by facilitating the membrane translocation of protein kinase B/Akt. J. Cell Biol. 160, 1001-1008 (2003).
79. Zhang, Y., Chen, K., Tu, Y. & Wu, C. Distinct roles of two structurally closely related focal adhesion proteins, α-parvins and β-parvins, in regulation of cell morphology and survival. J. Biol. Chem. 279, 41695-41705 (2004).
80. Zhang, Y. et al. Assembly of the PINCH-ILK-CH-ILKBP complex precedes and is essential for localization of each component to cell-matrix adhesion sites. J. Cell Sci. 115, 4777-4786 (2002).
81. Guo, L. & Wu, C. Regulation of fibronectin matrix deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J. 16, 1298-1300 (2002).
82. Nikolopoulos, S. N. & Turner, C. E. Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J. Biol. Chem. 276, 23499-23505 (2001).
83. Frish, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626 (1984).
84. Guadagno, T. M., Ohtsubo, M., Roberts, J. M. & Assoian, R. K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262, 1572-1575 (1993).
85. Zhu, X., Ohtsubo, M., Bohmer, R. M., Roberts, J. M. & Assoian, R. K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J.Cell Biol. 133, 391-403 (1996).
86. D'Amico, M. et al. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways. J. Biol. Chem. 275, 32649-32657 (2000).
87. Li, F., Liu, J., Mayne, R. & Wu, C. Identification and characterization of a mouse protein kinase that is highly homologous to human integrin-linked kinase. Biochim. Biophys. Acta 1358, 215-220 (1997).
88. Terpstra, L. et al. Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J. Cell Biol. 162, 139-148 (2003).
89. Grashoff, C., Aszodi, A., Sakai, T., Hunziker, E. B. & Fassler, R. Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep. 4, 432-138 (2003).
90. Troussard, A. A., Tan, C., Yoganathan, T. N. & Dedhar, S. Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol. Cell. Biol. 19, 7420-7427 (1999).
91. Kumar, A. S., Naruszewicz, I., Wang, P., Leung-Hagesteijn, C. & Hannigan, G. E. ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 23, 3454-3461 (2004).
92. Quelo, I., Gauthier, C., Hannigan, G. E., Dedhar, S. & St-Arnaud, R. Integrin-linked kinase (ILK) regulates the nuclear entry of the c-JUN coactivator αNAC and its coactivation potency. J. Biol. Chem. 279, 43893-43899 (2004).
93. Troussard, A. A. et al. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J. Biol. Chem. 278, 22374-22378 (2003). Genetic approach showing that ILK is essential for promoting phosphorylation of AKT on Ser473.
94. Gary, D. S., Milhavet, O., Camandola, S. & Mattson, M. P. Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J. Neurochem. 84, 878-890 (2003).
95. Nicholson, K. M. & Anderson, N. G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14, 381-395 (2002).
96. Tan, C., Mui, A. & Dedhar, S. Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-κS-dependent manner. J. Biol. Chem. 277, 3109-3116 (2002).
97. Makino, K., Day, C. P., Wang, S. C., Li, Y. M. & Hung, M. C. Upregulation of IKKα/IKKβ by integrin-linked kinase is required for HER2/neu-induced NF-κB antiapoptotic pathway. Oncogene 23, 3883-3887 (2004).
98. Wang, X. Q., Sun, P. & Paller, A. S. Inhibition of integrin-linked kinase/protein kinase B/Akt signaling: mechanism for ganglioside-induced apoptosis. J. Biol. Chem. 276, 44504-44511 (2001).
99. Hill, M. M., Feng, J. & Hemmings, B. A. Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12, 1251-1255 (2002).
100. Feng, J., Park, J., Cron, P., Hess, D. & Hemmings, B. A. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 279, 41189-41196 (2004).
101. Chun, S. J., Rasband, M. N., Sidman, R. L., Habib, A. A. & Vartanian, T. Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J. Cell Biol. 163, 397-408 (2003).
102. Novak, A. et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl Acad. Sci. USA 95, 4374-4379 (1998).
103. Wu, C. et al. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J. Biol. Chem. 273, 528-536 (1998).
104. Li, Y., Yang, J., Dai, C., Wu, C. & Liu, Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchyma transition and renal interstitial fibrogenesis. J. Clin. Invest. 112, 503-516 (2003).
105. Somasiri, A., Howarth, A., Goswami, D., Dedhar, S. & Roskelley, C. D. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J. Cell Sci. 114, 1125-1136 (2001).
106. White, D. E., Cardiff, R. D., Dedhar, S. & Muller, W. J. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene 20, 7064-7072 (2001). This study provided in vivo demonstration that increased expression of ILK in breast epithelial cells promotes hyperplasia and tumour formation.
107. Barbera, M. J. et al. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23, 7345-7354 (2004).
108. Lee, Y. I., Kwon, Y. J. & Joo, C. K. Integrin-linked kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition. Biochem. Biophys. Res. Commun. 316, 997-1001 (2004).
109. Muraoka, R. S. et al. Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551-1559 (2002).
110. Troussard, A. A. et al. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19, 5444-5452 (2000).
111. Rosenberger, G., Jantke, I., Gal, A. & Kutsche, K. Interaction of αPIX (ARHGEF6) with β-parvin (PARVB) suggests an involvement of αPIX in integrin-mediated signaling. Hum. Mol. Genet. 12, 155-167 (2003).
112. Muranyi, A. et al. Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem. J. 366, 211-216 (2002).
113. Xie, D. et al. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways. Cancer Res. 64, 1987-1996 (2004).
114. Graff, J. R. et al. Integrin-linked kinase expression increases with prostate tumor grade. Clin. Cancer Res. 7, 1987-1991 (2001).
115. Bravou, V., Klironomos, G., Papadaki, E., Stefanou, D. & Varakis, J. Integrin-linked kinase (ILK) expression in human colon cancer. Br. J. Cancer 89, 2340-2341 (2003).
116. Marotta, A., Parhar, K., Owen, D., Dedhar, S. & Salh, B. Characterisation of integrin-linked kinase signailing in sporadic human colon cancer. Br. J. Cancer 88, 1755-1762 (2003).
117. Marotta, A. et al. Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene 20, 6250-6257 (2001).
118. Ito, R. et al. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch. 442, 118-123 (2003).
119. Ahmed, N. et al. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritonea tumour fluid. J. Pathol. 201, 229-237 (2003).
120. Ahmed, N., Oliva, K., Rice, G. E. &, Quinn, M. A. Cell-free 59 kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma. Clin. Cancer Res. 10, 2415-2420 (2004).
121. Chung, D. H. et al. ILK (β1-integrin-linked protein kinase): a novel immunohistochemical marker for Ewing's sarcoma and primitive neuroectodermal tumour. Virchows Arch. 433, 113-117 (1998).
122. Chen, P., Shen, W. Z. & Karnik, P. Suppression of malignant growth of human breast cancer cells by ectopic expression of integrin-linked kinase. Int. J. Cancer 111, 881-891 (2004).
123. Di-Poi, N., Tan, N. S., Michalik, L., Wahli, W. & Desvergne, B. Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell 10, 721-733 (2002).
124. He, T. C., Chan, T. A., Vogelstein, B. & Kinzler, K. W. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345 (1999).
125. Park, B. H., Vogelstein, B. & Kinzler, K. W. Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells. Proc. Natl Acad. Sci. USA 98, 2598-2603 (2001).
126. Gupta, R. A. et al. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth. Nature Med. 10, 245-247 (2004).
127. Stephen, R. L. et al. Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines. Cancer Res. 64, 3162-3170 (2004).
128. Cordes, N. Overexpression of hyperactive integrin-linked kinase leads to increased ceuular radiosensitivity. Cancer Res. 64, 5683-5692 (2004).
129. Edwards, L. A., Shabbits, J. A., Bally, M. & Dedhar, S. Integrin-linked kinase (ILK) in combination molecular targeting. Cancer Treat. Res. 119, 59-75 (2004).
130. Nagata, Y. et al. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell 6, 117-127 (2004).
131. Lin, X., Qadota, H., Moerman, D. G. & Williams, B. D. C. elegans PAT-6/actopaxin plays a critical role in the assembly of integrin adhesion complexes in vivo. Curr. Biol. 13, 922-932 (2003).
132. Edwards, L. et al. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumour growth. Oncogene (in the press).
133. Yau, C. et al. Inhibition of integrin-linked kinase(ILK) by a selective small molecule inhibitor, QLT054 inhibits the PI3K/PKB/mTOR, STAT-3 and FKHR pathways, tumour growth and enhances gemdtabine-induced apoptosis in human primary pancreatic cancer xenografts. Cancer Res. (in the press).